OrthoPediatrics Corp (KIDS)
32.83
+1.02
(+3.21%)
USD |
NASDAQ |
May 03, 16:00
32.81
-0.02
(-0.06%)
After-Hours: 20:00
OrthoPediatrics Research and Development Expense (Quarterly): 2.747M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.747M |
| September 30, 2023 | 2.387M |
| June 30, 2023 | 2.792M |
| March 31, 2023 | 2.27M |
| December 31, 2022 | 2.034M |
| September 30, 2022 | 2.206M |
| June 30, 2022 | 1.747M |
| March 31, 2022 | 2.027M |
| December 31, 2021 | 1.608M |
| September 30, 2021 | 1.302M |
| June 30, 2021 | 1.325M |
| March 31, 2021 | 1.308M |
| December 31, 2020 | 2.05M |
| September 30, 2020 | 1.077M |
| June 30, 2020 | 0.881M |
| March 31, 2020 | 1.265M |
| December 31, 2019 | 1.905M |
| Date | Value |
|---|---|
| September 30, 2019 | 1.396M |
| June 30, 2019 | 1.234M |
| March 31, 2019 | 1.213M |
| December 31, 2018 | 1.277M |
| September 30, 2018 | 1.122M |
| June 30, 2018 | 1.115M |
| March 31, 2018 | 1.218M |
| December 31, 2017 | 0.941M |
| September 30, 2017 | 1.127M |
| June 30, 2017 | 0.668M |
| March 31, 2017 | 0.687M |
| December 31, 2016 | 0.624M |
| September 30, 2016 | 0.501M |
| June 30, 2016 | 0.589M |
| March 31, 2016 | 0.507M |
| March 31, 2015 | 0.479M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.881M
Minimum
Jun 2020
2.792M
Maximum
Jun 2023
1.766M
Average
1.747M
Median
Jun 2022
Research and Development Expense (Quarterly) Benchmarks
| Anika Therapeutics Inc | 7.585M |
| The Cooper Companies Inc | 39.50M |
| Staar Surgical Co | 10.87M |
| NexGel Inc | 0.013M |
| Innovative Eyewear Inc | 0.1208M |